Literature DB >> 17027114

The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization.

Kang-Seuk Choi1, Jin-Ju Nah, Young-Joon Ko, Yong-Joo Kim, Yi-Seok Joo.   

Abstract

The envelope (E) protein of WNV plays an important role in the virus neutralization. Using a mAb 5E8, a neutralizing epitope on the domain III of the E of the New York strain of WN virus was characterized. Results from neutralization-escape mutants and site-directed mutagenesis revealed that the 5E8 epitope is a highly conformation dependent epitope consisting of at least residues E330, E332 and E367 on the domain III. Besides known critical neutralizing epitopes E330 and E332, our results indicate that residue E367, a component of DE loop on the domain III, appeared to be associated with neutralization but little with neuroinvasion of the virus, as reported previously (Beasley et al., 2002).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027114     DOI: 10.1016/j.virusres.2006.09.002

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  12 in total

1.  Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.

Authors:  Orly Gershoni-Yahalom; Shimon Landes; Smadar Kleiman-Shoval; David Ben-Nathan; Michal Kam; Bat-El Lachmi; Yevgeny Khinich; Michael Simanov; Itzhak Samina; Anat Eitan; Irun R Cohen; Bracha Rager-Zisman; Angel Porgador
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

2.  Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.

Authors:  Shuliu Zhang; Evgeniy I Bovshik; Rodrigo Maillard; Gregory D Gromowski; David E Volk; Catherine H Schein; Claire Y-H Huang; David G Gorenstein; James C Lee; Alan D T Barrett; David W C Beasley
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

3.  Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.

Authors:  Jessica A Plante; Maricela Torres; Claire Y-H Huang; David W C Beasley
Journal:  Virology       Date:  2016-06-07       Impact factor: 3.616

4.  Monoclonal antibody-based competitive enzyme-linked immunosorbent assay for detecting and quantifying West Nile virus-neutralizing antibodies in horse sera.

Authors:  Kang-Seuk Choi; Young-Joon Ko; Jin-Ju Nah; Yong-Joo Kim; Shien-Young Kang; Kyoung-Jin Yoon; Yi-Seok Joo
Journal:  Clin Vaccine Immunol       Date:  2006-11-29

5.  Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Authors:  Soila Sukupolvi-Petty; S Kyle Austin; Whitney E Purtha; Theodore Oliphant; Grant E Nybakken; Jacob J Schlesinger; John T Roehrig; Gregory D Gromowski; Alan D Barrett; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

Review 6.  The structural immunology of antibody protection against West Nile virus.

Authors:  Michael S Diamond; Theodore C Pierson; Daved H Fremont
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

Review 7.  Progress on the development of therapeutics against West Nile virus.

Authors:  Michael S Diamond
Journal:  Antiviral Res       Date:  2009-06-06       Impact factor: 5.970

8.  Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.

Authors:  Soila Sukupolvi-Petty; James D Brien; S Kyle Austin; Bimmi Shrestha; Sherri Swayne; Kristen Kahle; Benjamin J Doranz; Syd Johnson; Theodore C Pierson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

9.  A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.

Authors:  Gunther Spohn; Gary T Jennings; Byron Ee Martina; Iris Keller; Markus Beck; Paul Pumpens; Albert Dme Osterhaus; Martin F Bachmann
Journal:  Virol J       Date:  2010-07-06       Impact factor: 4.099

Review 10.  Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex.

Authors:  Jody Hobson-Peters
Journal:  J Biomed Biotechnol       Date:  2012-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.